Menu
Currency
GWAS Study

Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.

Gudbjartsson DF, Holm H, Indridason OS et al.

20686651 PubMed ID
GWAS Study Type
46862 Participants
99 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GD
Gudbjartsson DF
HH
Holm H
IO
Indridason OS
TG
Thorleifsson G
EV
Edvardsson V
SP
Sulem P
DV
de Vegt F
DF
d'Ancona FC
DH
den Heijer M
WJ
Wetzels JF
FL
Franzson L
RT
Rafnar T
KK
Kristjansson K
BU
Bjornsdottir US
EG
Eyjolfsson GI
KL
Kiemeney LA
KA
Kong A
PR
Palsson R
TU
Thorsteinsdottir U
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Chronic kidney disease (CKD) is a worldwide public health problem that is associated with substantial morbidity and mortality. To search for sequence variants that associate with CKD, we conducted a genome-wide association study (GWAS) that included a total of 3,203 Icelandic cases and 38,782 controls. We observed an association between CKD and a variant with 80% population frequency, rs4293393-T, positioned next to the UMOD gene (GeneID: 7369) on chromosome 16p12 (OR = 1.25, P = 4.1x10(-10)). This gene encodes uromodulin (Tamm-Horsfall protein), the most abundant protein in mammalian urine. The variant also associates significantly with serum creatinine concentration (SCr) in Icelandic subjects (N = 24,635, P = 1.3 x 10(-23)) but not in a smaller set of healthy Dutch controls (N = 1,819, P = 0.39). Our findings validate the association between the UMOD variant and both CKD and SCr recently discovered in a large GWAS. In the Icelandic dataset, we demonstrate that the effect on SCr increases substantially with both age (P = 3.0 x 10(-17)) and number of comorbid diseases (P = 0.008). The association with CKD is also stronger in the older age groups. These results suggest that the UMOD variant may influence the adaptation of the kidney to age-related risk factors of kidney disease such as hypertension and diabetes. The variant also associates with serum urea (P = 1.0 x 10(-6)), uric acid (P = 0.0064), and suggestively with gout. In contrast to CKD, the UMOD variant confers protection against kidney stones when studied in 3,617 Icelandic and Dutch kidney stone cases and 43,201 controls (OR = 0.88, P = 5.7 x 10(-5)).

1,689 European ancestry cases, 37,076 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

46862
Total Participants
GWAS
Study Type
Yes
Replicated
1,972 European ancestry cases, 6,125 European ancestry controls
Replication Participants
European
Ancestry
Iceland, Netherlands
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.